Biosense Webster logo

Biosense Webster

Discover a New Possible

3404 employees · est. 1970 · Irvine, United States

VS
Ultromics logo

Ultromics

Ultromics is transforming the detection of heart failure using artificial intelligence for echocardiography.

85 employees · est. 2017 · Oxford, United Kingdom

Biosense Webster is the older company (1970 vs 2017); Biosense Webster is the larger of the two.

Side-by-Side Comparison

Biosense Webster Ultromics
Founded
1970 older 2017
Headquarters
Irvine, United States Oxford, United Kingdom
Employees
3404 larger 85
Industry
Biotechnology, Health Care AI, Computer Vision, Health Care
Funding Stage
Not tracked yet Series C
Total Funding
Not tracked yet $93.70M
Funding Rounds
Not tracked yet 6
Services
Not tracked yet AI-powered HFpEF detection, AI-powered Cardiac Amyloidosis detection, EchoGo® Integration and analytics, Automated diagnostic reporting
Target Customers
Not tracked yet Healthcare Institutions, Cardiologists, Clinical Decision Support Teams, Hospitals and Clinics
Taxonomy
Biosense Webster, Inc., Heart Rhythm Disorders, Atrial Fibrillation, Electrophysiology, Catheter Ablation, Medical Device, Medical Technology, Cardiac Treatment, Heart Health, EP, MedTech, Johnson & Johnson, Arrhythmia, Innovation Artificial_intelligence, Echocardiography, Heart_failure_detection, Precision_medicine, Cardiac_ultrasound, HFpEF, Clinical_diagnostics, Healthcare_technology, Medical_imaging, Cardiology, Partnership_with_mayo_clinic, Partnership_with_johnson_and_johnson, Partnership_with_pfizer, Early_intervention, Heart_disease_dataset
Website
biosensewebster.com ultromics.com
Biosense Webster logo

About Biosense Webster

Biosense Webster is a global leader in the biotechnology and healthcare industries, dedicated to the science, diagnosis, and treatment of heart rhythm disorders. Established in 1970 and headquartered in the United States, it is part of the Johnson and Johnson Medtech family. Their slogan "Discover a...

Ultromics logo

About Ultromics

Ultromics, founded in 2017, is at the forefront of revolutionizing heart failure detection through its innovative use of artificial intelligence in echocardiography. Headquartered in the United Kingdom, the company stands out within the AI, Computer Vision, and Health Care industries. Their flagsh...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Biosense Webster and Ultromics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Biosense Webster and Ultromics — by email.

Frequently Asked Questions

Biosense Webster — Discover a New Possible. Ultromics — Ultromics is transforming the detection of heart failure using artificial intelligence for echocardiography.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biosense Webster has raised undisclosed funding while Ultromics has raised $93.70M.
Biosense Webster and Ultromics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biosense Webster with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy